التفاصيل البيبلوغرافية
| العنوان: |
Incidence and risk factors of myelosuppression of linezolid in patients with drugresistant tuberculosis: A scoping review. |
| المؤلفون: |
Putra, Oki Nugraha, Purnamasari, Telly |
| المصدر: |
One Health Bulletin; Mar2024, Vol. 4 Issue 1, p1-8, 8p |
| مصطلحات موضوعية: |
LEUKOCYTE count, NUCLEOSIDE reverse transcriptase inhibitors, SOFT tissue infections, DRUG side effects, MEDICAL personnel, MULTIDRUG-resistant tuberculosis |
| مستخلص: |
This document summarizes a scoping review on the use of linezolid in the treatment of drug-resistant tuberculosis (DR-TB). The review found that myelosuppression, particularly anemia, was a common side effect of linezolid treatment in DR-TB patients. Risk factors for myelosuppression included HIV co-infection, age, and high exposure to linezolid. Regular monitoring of hematologic parameters is recommended during linezolid treatment, especially in patients with these risk factors. The document also provides insights into dosing strategies, pharmacokinetics, and the importance of considering factors such as age and renal function when using linezolid in TB treatment. [Extracted from the article] |
|
Copyright of One Health Bulletin is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder